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BY-NC-ND license (http://creativecomIn the past decades improved surgical techniques and better neonatal supportive care have re-
sulted in reduced mortality of patients with esophageal atresia (EA), with or without tracheoe-
sophageal fistula, and in increased prevalence of long-term complications, especially
respiratory manifestations. This integrative review describes the techniques currently used
in the pediatric clinical practice for assessing EA-related respiratory disease. We also present
a novel algorithm for the evaluation and surveillance of lung disease in EA. A total of 2813 ar-
ticles were identified, of which 1451 duplicates were removed, and 1330 were excluded based
on review of titles and abstracts. A total of 32 articles were assessed for eligibility. Six reviews
were excluded, and 26 original studies were assessed. Lower respiratory tract infection seems
frequent, especially in the first years of life. Chronic asthma, productive cough, and recurrent
bronchitis are the most common respiratory complaints. Restrictive lung disease is generally
reported to prevail over the obstructive or mixed patterns, and, overall, bronchial hyperre-
sponsiveness can affect up to 78% of patients. At lung imaging, few studies detected bronchi-
ectasis and irregular cross-sectional shape of the trachea, whereas diffuse bronchial
thickening, consolidations, and pleural abnormalities were the main chest X-ray findings.
Airway endoscopy is seldom included in the available studies, with tracheomalacia and
tracheobronchial inflammation being described in a variable proportion of cases. A complete
diagnostic approach to long-term respiratory complications after EA is mandatory. In the pres-
ence of moderate-to-severe airway disease, patients should undergo regular tertiary care
follow-up with functional assessment and advanced chest imaging.
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Follow-up of lung disease in esophageal atresia 91. Introduction
Esophageal atresia (EA) with or without tracheoesophageal
fistula (TEF) occurs in one per 3000 live births.1e3 In recent
decades, improved surgical techniques and better neonatal
supportive care have resulted in reduced mortality and
increased prevalence of long-term disease-related compli-
cations, the most frequent of which include respiratory
manifestations.4
Recurrent-to-chronic respiratory symptoms may upset
daily life of EA survivors,5 and this is the reason why the
assessment of pulmonary disease is recommended in these
patients. This integrative review describes the various
techniques currently used in pediatric clinical practice for
assessing EA-related respiratory disease. Moreover, we
present a novel algorithm for the evaluation and surveil-
lance of lung disease in EA survivors. We carried out an
electronic keyword literature search for English articles
published on this topic up to September 22, 2015, in the
Scopus, Web of Science, PubMed, and MEDLINE databases.
We excluded the studies conducted exclusively on adults,
but included those with a study population comprising
children (or adolescents) and adults. The terms “esopha-
geal atresia” AND (lung OR respiratory OR pulmonary OR
airway or spirometry or complications or diagnostic tools)
were used as keywords in combination, and the studies
found were evaluated for selecting relevant literature. In
addition, a manual search was conducted to evaluate re-
view articles’ references. Literature reviews on diagnostic
procedures for EA-related pulmonary disease prompted us
to develop a novel algorithm for the evaluation and sur-
veillance of lung disease in EA survivors.
2. Etiology
The etiology of pulmonary manifestations following EA
repair is multifaceted. Because newborns with EA have an
increased risk of premature birth that may initiate the
clinical scenario,6 the association with anomalies such as
tracheomalacia and lung hypoplasia may significantly
contribute to respiratory morbidity since birth.2 Gastroin-
testinal symptoms (i.e., regurgitation and/or feeding diffi-
culties with repetitive cough during swallowing, and/or
dysphagia and heartburn likely due to peptic esophagitis
and Barrett’s esophagus) represent the major complaints at
any age, and an association of gastrointestinal and respi-
ratory symptoms has been hypothesized to imply a corre-
lation between esophageal and lung dysfunction.1,5,7
Indeed, esophageal dysmotility and gastroesophageal
reflux (GER) may cause and/or worsen wheezing, bronchial
asthma, and pneumonia.8 Although the underlying mecha-
nisms are still being debated, literature suggests that
chronic asthma is likely elicited by a reflex mechanism and
that recurrent pneumonia may be explained by repetitive
acid aspiration.9,10 Chronic airway inflammation with bouts
of infection can eventually result in segmental or even
lobar damage leading to the development of severe, life-
threatening lung disease in a proportion of patients.11e14
Finally, recurrent TEF may further complicate the clinical
course.15 Following EA-TEF repair, structural anomalies
persist in both the trachea and the esophagus, and chestwall deformities, exacerbated by thoracotomy, may further
contribute to alter pulmonary function.23. Respiratory complications
Patients with EA with or without TEF experience respiratory
complaints more often and more persistently than other
individuals, and recurrent bronchitis, chronic cough,
repeated pneumonia, and asthma-like wheezing represent
the major clinical manifestations.11,16
Lower respiratory tract infection is abnormally com-
mon especially in the first years of life, with more than
five annual respiratory tract infections and a rate of more
than three attacks of bronchitis per year of up to
78%.17,18 In a study from Finland, aspiration pneumonia
likely related to impaired esophageal peristalsis and
esophageal stricture was reported in approximately 50%
of affected children, although they did not experience
more current respiratory or esophageal symptoms than
those without.12
Coughs with sputum production and recurrent bron-
chitis are significantly more common among patients with
repaired EA than among healthy individuals,19 and
although respiratory morbidity tends to improve with age,
chronic cough, associated with bronchial constriction and
hyperresponsiveness, can persist or even become more
frequent in adulthood.20 As a consequence of repeated
bouts of lower airways infection, bronchiectasis may also
develop.21
Although some respiratory complications may be
accounted for by documented tracheomalacia, esophageal
dysmotility, GER disease (GERD), or surgical complications,
a high proportion of EA survivors have abnormal pulmonary
function that is apparently unrelated to these conditions.2
A restrictive pattern generally prevailing over obstructive
or restrictive-obstructive airway disease has been
described in up to 96% of children, adolescents, and adults
previously treated for EA with or without TEF.1,12,22e24
Interestingly, approximately one-third of a Finnish pediat-
ric population had restrictive or obstructive defects that
were apparently unrelated to current respiratory or
esophageal symptoms.12 In the same study, bronchial
hyperresponsiveness was found to be severe/moderate or
mild in 26% or 52% of the cases, respectively. Airflow
obstruction may be explained by several mechanisms
including small airway disease or proximal obstruction due
to airway malacia or epithelial damage caused by GERD and
recurrent episodes of bronchitis or aspiration pneumonia
worsened by poor tracheal clearance, or decreased lung
growth during infancy.25 Multiple potential predisposing
factors to restrictive lung disease are also congenital or
acquired vertebral or chest wall abnormalities (i.e., scoli-
osis or postoperative rib fusions), surgical trauma, aspira-
tion, and/or recurrent chest infections.1
Chronic asthma is considered to be common in EA sur-
vivors, with significant bronchial inflammation also occur-
ring in patients with nonallergic asthma.13,26 Whatever the
initial trigger is, asthma significantly contributes to respi-
ratory morbidity in EA, and it might even worsen pre-
existing GERD.13
Table 1 Main findings from the 26 original articles that exclusively investigated respiratory disease in esophageal atresia
survivors.
Study Age (y) Lung
imaging
Pulmonary function
tests
Bronchoscopy Other Main findings
Dudley & Phelan18 1 to >9 d d d Clinical
outcome
Recurrent bronchitis
during the first 3 y (78%)
Milligan & Levison22 7e18 d Spirometry
MCT
d d Obstructive (54%) &
restrictive (21%) lung
diseases
Bronchial
hyperreactivity (65%)
Couriel et al31 8e17 d Spirometry
MCT
d Clinical
outcome
Bronchitis for > 8 y (25%)
Mild restrictive lung
disease
Bronchial
hyperreactivity (22%)
LeSoue¨f et al25 12e21 d Spirometry
Body
plethysmography
d d Significant reduction of
lung volumes in the
pneumonia group vs. the
nonpneumonia group
Chetcuti et al32 0e25 d Body
plethysmography
d d Daily cough (15%),
wheezing (40%),
bronchitis (34%)
RV increase (77%),
significant reduction in
VC & FEV1 in patients
who wheezed in the past
12 mo
Griscom & Martin40 2e21 CT Spirometry d d Bronchiectasis (40%)
Mild restrictive (20%) &
obstructive lung disease
(40%)
Chetcuti et al33 6e37 d Spirometry
Body
plethysmography
d d Reduced FEV1 (25%) &
RV/TLC ratio (41%)
Restrictive lung disease
(18%)
Chetcuti & Phelan11 1e37 d d d Clinical
outcome
In the 0e5-y age group,
pneumonia (50%),
recurrent pneumonia
(25%)
Persistent cough (32%
aged 0e5 y, 13% 5e10 y,
15% 10e15 y, & 9%>
15 y)
Typical harsh cough (71%
aged 0e5 y, 60% 5e10 y,
57% 10e15 y, & 40%>
15 y)
Beardsmore et al38 2e13 wk d Body
plethysmography
d d Thoracic gas volume
increase (33%),
abnormalities in airway
resistance pattern (78%),
airway resistance
increase (33%),
limitation of inspiratory
&expiratory airflow (11%)
Montgomery et al34 8e21 d Spirometry
Body
plethysmography
d Clinical
outcome
Asthma or bronchitis
(39%)
Obstructive (44%) &
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Table 1 (continued )
Study Age (y) Lung
imaging
Pulmonary function
tests
Bronchoscopy Other Main findings
Bicycle ergometer restrictive (55%) lung
disease
Decreased maximal
working capacity (53%)
Robertson et al35 7e28 X-ray Spirometry
Body
plethysmography
MCT
d Clinical
outcome
Respiratory symptoms
(72%), bronchiectasis
(4%), obstructive (12%),
restrictive (36%), &
mixed (4%) lung disease
Positive MCT (24%)
Somppi et al36 3.5e30 d Spirometry Yes Clinical
outcome
Reduced FEV1 (67%)
Tracheal inflammation
(37%). Respiratory
infections (29%),
recurrent dyspnea (28%),
& cough during the night
(37%)
Agrawal et al26 7e12 d Spirometry
Body
plethysmography
d d Restrictive lung disease
(67%)
Choudhury et al14 0 d to >30 d d d d Clinical
outcome
Aspiration & pneumonia
(13%) as early death
causes
Aspiration,
tracheomalacia, &
reactive airway disease
as late death causes
(59%)
Soto et al30 1e15 d Spirometry d d Restrictive lung disease
(50%)
Little et al28 18.7 d d d Clinical
outcome
Respiratory infections
(29%)
Sarnelli et al13 0.8e14.6 X-ray
HRCT
Perfusion
scintigraphy
d Yes d Family history of atopy
(40%) & allergic asthma
(10%), lobar
consolidations (80%),
bronchiectasis (20%)
Banjar21 1.25  2.4 CT Spirometry
Body
plethysmography
d d Tracheomalacia (29%),
bronchiectasis (17%),
obstructive (7%),
restrictive (20%), &
mixed lung disease (7%)
Lilja & Wester29 1e20 d d d Clinical
outcome
At 16e20 y, frequent
cough between (36%),
impaired exercise
capacity (20%),
respiratory infections
(40%), & shortness of
breath (53%)
Malmstro¨m et al12 9.7e19.4 d Spirometry
Histamine
challenge
test
Yes FeNO, clinical
outcome
Obstructive (30%) &
restrictive (35%) lung
diseases
Bronchial
hyperreactivity (78%)
Current respiratory
symptoms (44%),
(continued on next page)
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Table 1 (continued )
Study Age (y) Lung
imaging
Pulmonary function
tests
Bronchoscopy Other Main findings
wheezing (52%),
pneumonia (52%)
Mild (72%) & moderate
bronchitis in biopsies
(7%)
Abnormal FeNO (23%)
Gischler et al17 5e6.5 d Spirometry
Treadmill test
d FeNO, clinical
outcome
Reduced FEV1 (25%)
Abnormally low maximal
exercise tolerance (6.3%)
Normal FeNO
High proportion of
patients with >5
respiratory tract
infections in 5 y (74%)
Harrison et al37 7.6  2.2 d Spirometry
Forced
oscillation
technique
Body
plethysmography
d d Reduced Rrs6 (27%) &
Rrs8 (24%)
FEV1 significantly lower
in EA with TEF vs.
healthy controls
Peetsold et al8 13.2  2.9 d Spirometry
Body
plethysmography
Cardiopulmonary
exercise
testing
Yes d Obstructive lung disease
(13%)
FVC & TLC significantly
lower in EA with TEF vs.
patients with
gastroesophageal reflux
disease
Spoel et al39 24e66 wk d Body
plethysmography
d d Obstructive lung disease
(19%)
Legrand et al23 13.3 d Spirometry d Clinical
outcome
Chronic cough (19%) &
dyspnea (37%)
Obstructive (50%) or
restrictive (11%) lung
disease
Beucher et al24 8.5 X-ray Spirometry
MCT
Bicycle ergometer
d d Bilateral opacities, right
lower lobe infiltrate, or
pleural abnormalities
(10%)
Obstructive (19%) &
restrictive (23%) lung
disease
Bronchial
hyperreactivity (39%)
Reduced ventilation
reserve (45%)
CT Z computed tomography; EA Z esophageal atresia; FeNO Z fractional concentration of exhaled nitric oxide; FEV1 Z forced
expiratory volume in one second; FVC Z forced vital capacity; HRCT Z high-resolution computed tomography; MCT Z methacholine
challenge test; Rrs6 Z resistance at 6 Hz; Rrs8 Z resistance at 8 Hz; RV Z residual volume; TEF Z tracheoesophageal fistula;
TLC Z total lung capacity; VC Z vital capacity.
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With improved patient survival due to better neonatal care
and surgery, the importance of recognition and manage-
ment of pulmonary disease has increased. Table 1 summa-
rizes the main findings from 26 original articles that
exclusively investigated respiratory disease in EA survivors.Several studies focused only on clinical outcomes,27e29
whereas others also included functional assessment by
spirometry,30e38 airway challenge tests,12,24 and/or lung
volumes measurement.8,39 The restrictive pattern was
generally reported to prevail over the obstructive or mixed
ones, and, overall, bronchial hyperresponsiveness was
found in up to 78% of patients.12 Of note, there were a few
Follow-up of lung disease in esophageal atresia 13studies on chest imaging findings, which were reported in
only five articles.13,21,24,35,40 In particular, three chest
computed tomography (CT) studies detected bronchiec-
tasis13,40 and irregular cross-sectional shape of the tra-
chea21 in a subgroup of patients, respectively. Chest CT
findings may also include consolidations and/or bronchiec-
tasis (Figure 1). By contrast, diffuse bronchial thickening,
consolidations, and pleural abnormalities were the main
chest X-ray findings described in a minority of pa-
tients.13,24,35 Airway endoscopy was seldom included in the
available studies, with tracheomalacia representing a
common finding8,12,41 and tracheobronchial inflammation
being described in a variable proportion of cases.12,36 In
addition to tracheomalacia and bronchomalacia, less com-
mon anatomic abnormalities may include ectopic or
absence of bronchus and congenital bronchial stenosis.1
Undoubtedly, evaluation of the airways structure via flex-
ible bronchoscopy can help identify these problems in in-
fants and children before EA/TEF repair, or also in those
with persistent respiratory symptoms after EA/TEF
surgery.12,13Figure 1 Chest high-resolution computed tomography from
two children with esophageal atresia and tracheoesophageal
fistula repaired at birth and followed at our department: (A)
left lower lobe consolidations and (B) left lower lobe consoli-
dation with bronchiectasis.Although several articles on the main long-term respi-
ratory complications in EA repair survivors have been pub-
lished, a shared executive protocol has never been
developed, nor have the available diagnostic tools been
ordered in a management algorithm. Indeed, the few
studies regarding the practical management of pulmonary
complications in EA survivors and their heterogeneity make
the development of an evidence-based operative algorithm
virtually impossible. Nevertheless, due to the severe
chronic complaints that some patients may experience and
the impact on the healthcare costs, we propose a novel
synthetic management algorithm (Figure 2), which may be
helpful for clinicians dealing with lung disease secondary to
EA. Basically, procedures are selected on the basis of the
current clinical features. Present literature does not
specify the timing of both follow-up visits and functional/
chest imaging work-up. We suggest that basic procedures
including transcutaneous pulse oximetry (SpO2), chest ra-
diographs, and lung function tests (the latter only on
cooperating patients) are at least obtained in all patients at
baseline. We also propose that EA survivors, with or without
TEF, should be differentiated between those with mild
airway disease and those with moderate-to-severe airway
disease. In particular, patients with respiratory symptoms
(persistent cough, recurrent-to-persistent wheezing,
recurrent respiratory infections) who show slight abnor-
malities or normal results of SpO2 at rest (ranging from 90%
to 93%),42,43 and/or chest radiography, and/or spirometry
(i.e., forced expiratory volume in 1 second and forced vital
capacity  70% predicted)44 are defined as having mild
airway disease. Conversely, patients with respiratory
symptoms and more relevant abnormalities of SpO2 at rest,
and/or chest radiography, and/or spirometry are defined as
having moderate-to-severe airway disease. We suggest that
only the latter cases undergo regular tertiary care follow-
up, including more extensive lung function assessment
and advanced chest imaging (i.e., high-resolution CT and/
or magnetic resonance imaging). A complete diagnostic
approach to long-term respiratory complications after EA
should also include tracheobronchial endoscopy with
instillation of methylene blue for excluding recurrent TEF.5
Recurrent TEF should be corrected using laparoscopic
antireflux procedures to prevent lung damage.45,46 These
considerations lead to the conclusion that the evaluation of
these patients is most efficiently accomplished in a tertiary
care center where pediatric pulmonologists, gastroenter-
ologists, radiologists, and surgeons are all available.5. Conclusion
In patients following EA repair, recurrent-to-persistent
respiratory disease represents a major feature, especially
in early to middle childhood.47 The persistence or recur-
rence of troublesome clinical manifestations imposes a
scheduled follow-up of a large proportion of EA survivors,
ideally through a multidisciplinary care approach for
addressing their special needs. Pulmonary care of these
patients involves managing comorbidities and preventing or
minimizing damage to the lungs. Early detection and man-
agement of aspiration and other causes of recurrent-to-
persistent lower airways infections in this population may
History and physical exam
Severity-driven selection of diagnostic procedures
SpO2*
Chest radiography*
Spirometry (in cooperating patients)*
Also consider: body plethysmography for lung volumes measurement and maximal exercise test for exercise-induced symptoms
Mild airway disease
- Adequate primary care follow up
- Prompt aggressive treatment of airway infections
- Functional assessment, at least once per year
- Consider tertiary care referral in case of clinical 
deterioration
Moderate-to-severe airway disease
- Regular tertiary care follow up including functional 
assessment, at least every 6 months
- Advanced lung imaging (high resolution computed 
tomography, magnetic resonance), at least at baseline
- Consider airway endoscopy
SpO2 at rest from 90% to 93% and/or
normal-to-slightly abnormal chest radiography and/or
FEV1 ≥ 70% predicted and/or
FVC ≥ 70% predicted
SpO2 at rest < 90% and/or
relevant abnormalities at chest radiography and/or
FEV1 < 70% predicted and/or 
FVC < 70% predicted
Figure 2 Algorithm for the evaluation and surveillance of chronic pulmonary manifestations in esophageal atresia survivors with
or without tracheoesophageal fistula. * To be obtained in all patients. FEV1Z forced expiratory volume in 1 second; FVCZ forced
vital capacity; SpO2 Z arterial oxygen saturation measured by pulse oximetry.
14 V. Mirra et albe important to prevent decrements in pulmonary function
and serious long-term complications.3 A management al-
gorithm for the evaluation and surveillance of EA-related
respiratory disease based on the evidence from literature
review is proposed. Like all algorithms, it is not meant to
replace clinical judgment, but it should rather drive phy-
sicians to adopt a systematic approach to chronic pulmo-
nary manifestations in EA survivors.Ethical statement
This article does not contain any studies with human or
animal subjects performed by any author(s).
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